Picture of Ayala Pharmaceuticals logo

ADXS Ayala Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Advaxis To Continue To Explore Additional Options To Maximize Stockholder Value

Dec 17 (Reuters) - Advaxis Inc  ADXS.O :
    * ADVAXIS TO CONTINUE TO EXPLORE ADDITIONAL OPTIONS TO
MAXIMIZE
STOCKHOLDER VALUE
    * ADVAXIS INC - PROPOSAL 2 REVERSE STOCK SPLIT, A CONDITION
FOR
COMPLETING MERGER OF ADVAXIS AND BIOSIGHT, WAS NOT APPROVED
    * ADVAXIS INC - STOCKHOLDERS APPROVED PROPOSAL 1 IN SUPPORT
OF
BIOSIGHT MERGER

Source text for Eikon:  ID:nGNX1pbp2r 
Further company coverage:  ADXS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Ayala Pharmaceuticals

See all news